I am very concerned about the possibility that some may be using the concept of flexibility to roll back consumer protection.
We commend the Finance Committee Chairman Orrin Hatch and Ranking Member Ron Wyden for recently introducing legislation, S. 1827.
I want to put this in the context of the 320 million people who live in our country.
The record, the actual factual record, does not show that.
But it just seems to me that sunlight would be an antiseptic here that would really make a difference.
There are only two ways to hold people accountable for costs at the end of the day: you can have a consumer-driven system or a government-dr...
Price increases happen because the providers of these pharmaceutical products have the power to do so because taxpayers foot the bill.
the President has for months and months poured gasoline on the fires of uncertainty in the private insurance marketplace.
The chairman has been clear that he wants our committee to work on a bipartisan basis to help shape the future of Americans' health care.
I have introduced legislation to pull back the curtain on the broken drug-pricing system that burdens the country.
Choice and competition are essential to bringing down costs, and we ought to prioritize moving the needle on increasing choice and competiti...